CAR T-cell therapy is starting to enter the treatment conversations sooner with patients with multiple myeloma, according to ...

Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...

Single-dose CAR-T therapy potentially curative in multiple myeloma by Justin Jackson, Phys.org edited by Sadie Harley, reviewed by Robert Egan Editors' notes ...

Source Reference: Xia J, et al "Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm ...

Chimeric antigen receptor (CAR) natural killer (NK) cells are of increased interest compared to CAR-T cell therapy because CAR-NK cells can circumvent the challenges of graft-versus-host disease, ...

A 2012 study found people with multiple myeloma who had above-median expression levels of GPRC5D in their bone marrow had a 43.9% estimated overall survival at 48 months, compared with 70.2% ...

Find Clinical Trials About Clinical Studies Volunteering Diversity Language Assistance Resources Contact A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Patti Scialfa's Multiple Myeloma Diagnosis As Bruce Springsteen’s wife Patti Scialfa has been battling early-stage multiple myeloma, a rare and incurable type of blood cancer, since 2018, the iconic ...

Most people with multiple myeloma are diagnosed in their 60s, 70s or 80s. “Myeloma is predominantly a disease of aging, so the older you get, the more likely you are to get it,” Mohyuddin said.

CAR-T cell therapy is moving to earlier lines of multiple myeloma treatment. Elouise Wrisper’s cancer journey began with persistent back pain. It was 2021, and the retired teacher, who was active in ...